Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | Y013120 | IM / LA |
Patient inadvertently received a pediatric formulation of the Hepatitis A vaccine. Patient was administered a 0.5 mL pediatric dose of the Hepatitis A vaccine. In consultation with the nurse, it was determined that the appropriate course of action was to administer an additional 0.5 mL of the pediatric formulation on the same day to complete the standard 1.0 mL adult dose. The patient returned on same day 5/20/25 for second 0.5 ml pediatric dose and has been advised to return in six months for the second 1.0 mL adult dose to complete the vaccination series.
none
none
n/a
nkda
no